Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up Study of BRL-101 in the Treatment of Transfusion-dependent β-thalassemia

NCT06298630 is registered in ClinicalTrials.gov with Bioray Laboratories as lead sponsor.

NCT NCT06298630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06298630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up Study of BRL-101 in the Treatment of Transfusion-dependent β-thalassemia
Lead sponsor
Bioray Laboratories
Phase
Observational
Overall status
Recruiting
Start date
December 8, 2024
Completion date
October 15, 2038
Enrollment
45 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

thalassemia, beta